LA JOLLA—The Salk Institute mourns the loss of Richard “Rich” Murphy, who died March 24, 2022, in La Quinta, California at the age of 77. Murphy served as the Institute’s president and CEO from 2000 […]
Vaccination events still giving first doses, though pace has slowed considerably. Click here to view original post
Highly Accomplished Visionary with Proven Track Record of Healthcare Industry Leadership Highlighted by Game Changing Technologies and Investor Success SAN DIEGO, March 25, 2022 /PRNewswire/ — NeuraLace Medical, Inc., an emerging medical device company focused […]
Capitalizing on the diagonal relationship between phosphorus and carbon, researchers at the University of California San Diego report binding diphosphorus to a single metal ion center through coordination chemistry, something that had historically remained elusive. […]
– ZYNRELEF is the only local anesthetic with separate reimbursement in both the Hospital Outpatient and Ambulatory Surgical Center settings of care – SAN DIEGO, March 25, 2022 /PRNewswire/ — Heron Therapeutics, Inc. (Nasdaq: HRTX), […]
SAN DIEGO–(BUSINESS WIRE)—- $ARCT #ClinicalTrial–Arcturus Therapeutics to Participate in the Cantor Fitzgerald Virtual Rare Orphan Disease Summit Click here to view original post
SAN DIEGO and HOUSTON, March 25, 2022 /PRNewswire/ — ScienceMedia announces their partnership with Apex Mobile Clinical Research (AMCR), a provider of decentralized clinical trial solutions and services to underserved communities. AMCR will be using […]
Roy Baynes ? Professional sports teams cycle through free agency every year, and core veterans from championship clubs routinely splinter off in different directions. In a similar vein, Merck in particular has seen widespread turnover […]
SAN DIEGO, March 24, 2022 /PRNewswire/ — Inhibrx, Inc. (Nasdaq: INBX), a biotechnology company with four clinical programs in development and an emerging pre-clinical pipeline, announced today that data from INBRX-121 and INBRX-130 will be […]
MALVERN, Pa. & SAN DIEGO–(BUSINESS WIRE)—- $PHAS #Bentracimab–PhaseBio Pharmaceuticals Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Recent Business Highlights Click here to view original post
SAN DIEGO & TOKYO–(BUSINESS WIRE)–MEI Pharma, Inc. (NASDAQ: MEIP) and Kyowa Kirin Co., Ltd. (Kyowa Kirin, TSE: 4151), today provided an update after a recent meeting with the U.S. Food Drug Administration (FDA) to discuss […]
Andy Gilkison Joins HYLETE as NEW VP of Sales & Michael Sorel as Account Manager SAN DIEGO, March 24, 2022 /PRNewswire/ — HYLETE, the award-winning distinguished fitness apparel brand, is pleased to announce that Andy […]
From whiteboard to white coat: Roivant Social Ventures teams up with San Diego drug discovery center to bolster diversity in biopharma mbayer Thu, 03/24/2022 – 09:29 Click here to view original post
LA JOLLA—Salk Institute Professor Tony Hunter will receive the 2022 American Association for Cancer Research (AACR) Award for Lifetime Achievement in Cancer Research at the April annual meeting of AACR, the largest cancer research organization […]
ROTTERDAM, Netherlands and SAN DIEGO, March 24, 2022 /PRNewswire/ — Today, SkylineDx announced that their Merlin Test for melanoma patients was independently validated in a Swedish (European) cohort, where it could reduce approximately a third […]
SAN DIEGO and RESEARCH TRIANGLE PARK, N.C., March 24, 2022 /PRNewswire/ — Creyon Bio, Inc. (“Creyon Bio”), a drug development company engineering RNA-based medicines and their components (oligonucleotide-based medicines or OBMs) with predictable safety and […]
CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #LineageCellTherapeutics–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that Brian M. Culley, the Company’s Chief Executive […]
ST. LOUIS & SAN DIEGO–(BUSINESS WIRE)–Wugen, Inc., a clinical-stage biotechnology company developing a pipeline of off-the-shelf cell therapies to treat a broad range of hematological and solid tumor malignancies, today announced that management will participate […]
LA JOLLA, Calif.–(BUSINESS WIRE)—- $EQ #GVHD–Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders with high unmet medical need, today announced financial results for […]
SAN DIEGO–(BUSINESS WIRE)– #VERIFi–LIDE Biotech participates in Scientist.com’s VERIF.i® program, which offers standardized, independent, on-site lab inspections Click here to view original post
BioFluidica LiquidScan Next-Generation Testing Platform, Can Detect Diseases in 15 Minutes SAN DIEGO, March 23, 2022 /PRNewswire/ — BioFluidica, a privately held biotechnology company, today announced they have been awarded a continuation grant from the […]
SAN DIEGO–(BUSINESS WIRE)– #SeriesA–Ocelot Bio, Inc., a clinical-stage biopharmaceutical company focused on the development of innovative therapeutics to treat complications of end-stage liver disease (ESLD), today announced the close of a $36 million Series A […]
Phase 2 study is the first approved by the FDA and DEA to test psychedelic therapies in the area of binge eating disorders SAN DIEGO, March 23, 2022 /PRNewswire/ — Tryp Therapeutics (CSE: TRYP) (OTCQB: […]
LA JOLLA, Calif.–(BUSINESS WIRE)—- $EQ #GVHD–Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders with high unmet medical need, today announced two oral presentations […]
CARLSBAD, Calif.–(BUSINESS WIRE)–Thermo Fisher Scientific Inc., the world leader in serving science, today announced its collaboration with the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx) Initiative, Helix, and Rosalind aimed at developing […]
When you are staking your whole business on a make-or-break Phase III trial, failure can be devastating. Just ask Neurana Pharmaceuticals. The little San Diego biotech had enrolled 1,004 patients who suffer from pain due […]
Guardant counters that the lawsuit was filed as retaliation for raising concerns with antitrust regulators over Illumina’s Grail acquisition. Click here to view original post
SAN DIEGO–(BUSINESS WIRE)– #AI–GigaIO wins TACC’s first composable infrastructure contract, providing maximum flexibility to compose the right resources for each workload. Click here to view original post
A UC San Diego pilot study on parents of mass shooting victims finds that eight weeks of mindfulness training is effective in reducing trauma, depression, stress and grief caused by gun violence. Click here to […]
SAN DIEGO, March 22, 2022 /PRNewswire/ — Phanes Therapeutics, Inc. (Phanes), an emerging leader in innovative discovery research and clinical development in immuno-oncology announced today that it has received clearance from the US Food and […]
Copyright © 2022 Biotech Networks, LLC
